Evaluation of miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, miR107, miR125b-5p, and miR155a-5p levels in children and adolescents with attention deficit hyperactivity disorder.

Evaluation of miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, miR107, miR125b-5p, and miR155a-5p levels in children and adolescents with attention deficit hyperactivity disorder.

Neurosci Lett. 2014 Aug 11;

Authors: Kandemir H, Erdal ME, Selek S, Ay OI, Karababa IF, Kandemir SB, Ay ME, Yılmaz SG, Bayazıt H, Taşdelen B

Abstract
Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent childhood disorders, although disorders etiology and pathogenesis remains unknown, several theories about ADHD development have been proposed and many researchers believe that it is caused by both genetic and environmental factors. In this study we evaluated miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, miR107, miR125b-5p and miR155a-5p levels in child and adolescent ADHD patients. The research sample consisted a group of 52 ADHD patients, and 52 healthy volunteer controls. There was no significant difference in age and sex between the two groups (p>0.05). Mirna 18a-5p,22-3p, 24-3p, 106b-5p and 107 levels were statistically significantly decreased in ADHD patients(p<0.05). Mirna 155a-5p levels were increased in patients group (p<0.05). The positive predictive value (PPV) and negative predictive value of miR107 was estimated for the cut off point of 0.4480. PPV was 70% and NPV was 86.5% for the taken cut off point. There could be a close relationship between levels of circulating miRNAs and ADHD. If we could understand how the signaling pathways arranged by miRNAs, impact on CNS development, function and pathology this can improve our knowledge about ADHD etiology and treatment.
OBJECTIVE: Attention-deficit/hyperactivity disorder (ADHD) is characterized by developmentally inappropriate levels of inattention, hyperactivity, and impulsivity [1]. It is one of the most prevalent childhood disorders, occurring in 3-7% of school-aged children and representing one third to one half of referrals to child mental health services [2]. ADHD is more common in boys than girls, with ratios ranging from 3:1 to 10:1 [3]. A large proportion of children with ADHD are diagnosed with another psychiatric disorder [4]. Overwhelming evidence suggests that ADHD is not a childhood condition but a lifelong disorder [5]. Although the etiology and pathogenesis of ADHD remain unknown, several theories have been proposed, and many researchers believe it is caused by both genetic and environmental factors [6]. Segregation analysis of data from neurochemical studies in families comprising genetic, twin, and adoption relationships strongly suggest a genetic etiology [7]. Substantial genetic influence on the disorder has been identified, with heritability estimates ranging from 60 to 90% [8]. Studies have identified abnormal regulation of neurotransmitter systems, particularly dopamine [9]. Preliminary molecular genetic studies have implicated several candidate genes, including the dopamine D2 and D4 (DRD4-7) receptors as well as the dopamine transporter (DAT-1) [10]. The presence of the L allele of the serotonin transporter gene 5-HTTLPR is associated with decreased serotonin levels and increased risk of ADHD [11]. MicroRNAs (miRNAs) are evolutionally conserved small noncoding RNAs that regulate approximately 30% of human protein coding gene expression at the post-transcriptional level, and they play important roles in a wide variety of biological functions [12]. miRNAs control gene expression by inhibiting translation or facilitating degradation of their target mRNAs. Computational predictions indicate that thousands of genes could be targeted by miRNAs in mammals [13]. miRNAs are important for maintaining homeostasis at the neuromuscular junction. They also play an important role in synaptic plasticity in the central nervous system, and are involved in memory and mental retardation [14]. The ability of miRNAs to affect the activity of all biological pathways may underlie some of the difficulties associated with linking psychiatric disorders to specific causative genes [15]. The involvement of multiple signaling pathways in psychiatric disease complicates both the investigation of the underlying biological causes and efforts to identify effective therapies. Focusing on the roles of miRNAs in psychiatric diseases may lead not only to an explanation of the dysregulation of multiple pathways but also to novel therapies that can target entire gene networks. Perkins et al. examined the expression of 16 miRNAs in the prefrontal cortex in subjects with schizophrenia or schizoaffective disorder and found decreased expression of 15 miRNAs in patients with schizophrenia [16]. However, although miRNAs have been shown to be particularly abundant in the brain, their role in the development and activity of the nervous system remains largely unknown. In this study, we evaluated miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, miR107, miR125b-5p, and miR155a-5p levels in children and adolescents with ADHD. In selection of the miRNAs previous literature pointing out the potential underlying neurobiology (enzyme, carrier molecule, receptor etc.) of the disease were reviewed and potential miRNAs from the miRNA database (mirbase.org) that had both higher target scores and were available in our lab were chosen. Table 1 shows the features of the studied miRNAs METHOD: The research sample consisted a group of 52 patients from Harran University Faculty of Medicine Research Hospital, Child and Adolescent Psychiatry Clinic who were referred The clinic for the first time and diagnosed with ADHD, and 52 healthy volunteer controls. All patients were diagnosed as ADHD by a child psychiatrist according to DSM-IV-TR diagnostic criteria and they were treatment naive. In this study, the ADHD module of K-SADS-PL was used to make the diagnosis of ADHD [17]. Patients with a history of cardiovascular disorders, epilepsy, diabetes mellitus, psychotic disorders, pervasive developmental disorders or severe head injury were excluded. The healthy controls were recruited from healthy child outpatient unit. After complete description of the study to the subjects, a written informed consent was obtained from the parents as well as the assent of children and adolescents. All of the study procedures were in accordance with the Declaration of Helsinki. Ethics committee of the Harran University Medical School approved the trial. Also a semi-structured form was used to detect several socio demographic and clinical variables of the patients. The final patient and control groups displayed similar distribution in age and gender. Study was funded by Harran University Board of Scientific Research Projects (Funding Number: 12010). This study was a cross-sectional study and blood sampling was made once from both controls and patients. Total RNA was extracted from Peripheral Whole Blood using Tri-Reagent (Sigma). Reverse transcriptase reactions contained 5μl of extracted total RNA, 50nM stem-loop RT primer, 1× RT buffer, 0.25mM each of dNTPs, 50 units of modified M-MuLV Reverse Transcriptase (Thermo Scientific, Vilnius, Lithuania), 25 units of RiboLock RNase inhibitor (Thermo Scientific, Vilnius, Lithuania) and nuclease-free water to a total reaction volume of 15μl. The reaction was performed on an automated Thermal Cycler (Techne Flexigene, Cambridge, UK). RT-PCR conditions for 30min at 16°C, 30min at 42°C, 5min at 85°C and then held at 4°. Quantitative-Comparative CT (ΔΔCT) Real-time PCR was performed in an ABI Prism 7500 Real-Time PCR System (Applied Biosystems) using the SDS 2.0.6 software. The specific primers and fluorogenic ZNA™ probes for the microRNAs were designed using Primer Express 3.0 software (Applied Biosystems) and are listed in Table 2. The hsa-miR-26b-5p is used as control according to the Applied Biosystems application note cms_044972 (Applied Biosystems: http://ift.tt/1nZ2hEh). The mixed RNAs generated from the control group was used as a Reference RNA sample. Primers and probes were purchased from Metabion International AG, D-82152 Martinsried/Deutschland. The 25μl PCR included 3μl RT-PCR product, 12.5μl of 2X TaqMan Universal PCR Master Mix (Applied Biosystems), 900 nmol of each primer (Primer F and Universal Primer R) and 200 nmol TaqMan(®) probe. The reactions were incubated in a 96-well plate of preincubation at 50°C for 2minute and at 95°C for 10minute, followed by 40 cycles at 95°C for 15 second and at 60°C for 90 second. Amplifications and analysis were performed in an ABI Prism 7500 Real-Time PCR System (Applied Biosystems), using the SDS 2.0.6 software for allelic discrimination (Applied Biosystems). All reactions were run in triplicate. Relative expression of miRNA was calculated using 2-ΔΔct method. Higher ΔΔct values indicate lower expression rates. The data were processed and analyzed using the statistical package SPSS-11.5 for Windows. Normality of 2(-DDCT) values was checked by Shapiro Wilk test. In case of non-normal distribution, 2(-DDCT) values were expressed as median, first quartile (25(th) percentile), third quartile (75(th) percentile), and the comparison between groups was performed using the Mann-Whitney test. Box-plot graph was used to represent data distribution of miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, miR107, miR125b-5p and miR155a-5p variables according to the groups. Significant differences (two-tailed p) less than 0.05 were regarded as significant.
RESULTS: This study included 52 ADHD subjects with a mean age of 10.09±2.36 years (range, 7-17 years) and 52 control subjects with a mean age of 10.92±2.96 years (range, 7-17 years). No statistically significant differences were detected in age and sex between the two groups (p>0.05; Table 3). The levels of MiR18a-5p, miR22-3p, miR24-3p, miR106b-5p, and miR107 were significantly decreased in the ADHD subjects compared with controls (p<0.05). Additionally, decreased levels of miR-125b levels were observed, but this trend was not statistically significant (p>0.05). MiR155a-5p levels were increased in the patient group (p<0.05; Table 4). The receiver operator characteristic (ROC) graph was drawn for miR107. The positive predictive value (PPV) and negative predictive value of miR107 was estimated for the cut off point of 0.4480. PPV was 70% and NPV was 86.5% for the taken cut off point.
DISCUSSION: To our knowledge, this is the first study to evaluate miRNA levels in ADHD subjects; therefore, we compared our results with those in other psychiatric disorders. We found decreased levels of miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, and miR107 in ADHD subjects compared with controls. In a study examining the relationship between miR-18a and endogenous glucocorticoid receptor protein expression in rats, Uchida and Vreugdenhil suggested that levels of miR-18a could be an important susceptibility mechanism for stress-related disorders [18,19]. Recent studies reported genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis and long-term effects of glucocorticoid in patients with ADHD [20,21]. Muinos et al. reported that miR22 was associated with panic disorder and that it regulated several candidate genes and related pathways involved in anxiety. In his study miR-22 was the miRNA with the highest number of functional targets, with four genes being potentially repressed by this miRNA: the neurotrophic factor BDNF, the serotonin receptor HTR2C, monoamine oxidase A -MAOA- those which are also potential targets in neurobiology of ADHD. [22]. A history of childhood ADHD features among adults with panic disorder has been reported [23]. Moreau et al. reported dysregulation of miR22 in schizophrenia and bipolar disorders [24].

PMID: 25123444 [PubMed – as supplied by publisher]

via http://ift.tt/1kIYr72